Boston Scientific CorporationBSXNYSE
Loading
Cash Flow PerformanceElevated
Percentile Rank64
3Y CAGR+23.3%
5Y CAGR+3.1%
Year-over-Year Change
Free cash flow yield
3Y CAGR
+23.3%/yr
Annual compound
5Y CAGR
+3.1%/yr
Recent acceleration
Percentile
P64
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.59% | +28.8% |
| 2024 | 2.01% | -0.7% |
| 2023 | 2.03% | +46.8% |
| 2022 | 1.38% | -36.6% |
| 2021 | 2.18% | -2.0% |
| 2020 | 2.22% | +1.7% |
| 2019 | 2.19% | +17874.5% |
| 2018 | -0.01% | -100.4% |
| 2017 | 3.26% | +60.6% |
| 2016 | 2.03% | - |